Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Projected Market Size and Growth Rates for the Gene Editing Market From 2025 To 2029?

The market size for gene editing has seen a swift growth in the past few years. It is expected to rise from $8.82 billion in 2024, to $10.31 billion in 2025, with a compound annual growth rate (CAGR) of 17.0%. The historical growth can be credited to the discovery of CRISPR-Cas9, advancements in the field of genetic sequencing, breakthroughs in medical science, funding for scientific research, and the expansion of the biotechnology industry.

The market size of gene editing is predicted to undergo swift expansion in the forthcoming years. A compound annual growth rate (CAGR) of 18.9% is expected to push the market to a worth of $20.62 billion by 2029. This escalated growth during the forecast period will be a result of growth in regenerative medicine, development of agricultural applications, commercialization of gene therapy, improvements in precision and efficiency, and expansion of therapeutic applications. The forecast period will also witness several prevailing trends such as non-viral delivery systems, disease modeling and drug discovery, multiplex editing techniques, gene drives and population modification, along with innovations in base editing.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2486&type=smp

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theGene Editing Market?

The growing incidence of communicable diseases is propelling the gene editing market, as these techniques become essential for detecting and treating these diseases. Infectious agents, including bacteria, viruses, or parasites, cause communicable diseases, which can spread from person to person, animals, or from the environment. Increasingly, gene editing technologies are used to devise targeted strategies, capable of identifying and battling pathogens at a genetic level, thereby improving disease control and prevention efforts. For example, the World Economic Forum, a non-governmental international organization based in Switzerland, announced in 2023 that infections like influenza and respiratory syncytial virus (RSV) had seen a rise following the pandemic. Consequently, in the USA, by February 2023, there have been about 24 million illnesses, 260,000 hospital admissions, and 16,000 deaths from influenza. Furthermore, the World Health Organization reported in 2022 that around 10.6 million people across the world had contracted tuberculosis, leading to the death of 1.3 million people. Hence, communicable diseases are augmenting the growth of the gene editing market.

Which Segments in the Gene Editing Offer the Most Growth?

The gene editingmarket covered in this report is segmented –

1) By Technology: CRISPR; TALEN; ZFN

2) By Application: Animal Genetic Engineering; Plant Genetic Engineering; Cell Line Engineering

3) By End Users: Biotechnology; Pharmaceutical; Contract Research Organization

Subsegments:

1) By CRISPR: CRISPR-Cas9; CRISPR-Cas12; CRISPR-Cas13; CRISPR-based Gene Drives

2) By TALEN (Transcription Activator-Like Effector Nucleases): Custom TALENs; Commercial TALEN Kits

3) By ZFN (Zinc Finger Nucleases): Custom ZFNs; Commercial ZFN Kits

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=2486&type=smp

What Are the Fastest-Growing Geographies in the #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theGene Editing Market?# Market?

North America was the largest region in the gene editing market in 2024. Western Europe was the second largest region in the global gene editing market share. The regions covered in the gene editing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Current Market Growth and Trends in the Gene Editing Industry?

Key players in the gene editing industry are employing innovative gene-editing technologies, such as an approach reliant on distinct cell-penetrating peptides, to gain a competitive advantage in the market. This strategy could also accelerate the creation of advanced cell therapies for cancer and other diseases. For example, Penn Medicine, a prominent multi-hospital health system based in the US, discovered in April 2023 that protein fragments utilized by certain viruses for cell penetration could also be used to introduce CRISPR-Cas gene editing molecules into cells and their DNA-rich nuclei with exceptional efficiency and minimum cellular toxicity. Scientists anticipate this new method to be particularly valuable for modifying T cells and other patient-derived cells for cell therapies. This technique could potentially be applied to CAR T (chimeric antigen receptor T cell) therapy, a treatment that uses specially modified immune cells from a patient to combat cancer. This innovative approach to cell genetic modification offers enhanced speed, efficiency, and reduced cellular toxicity compared to existing methods.

View the full report here:

https://www.thebusinessresearchcompany.com/report/gene-editing-global-market-report

What Are the Key Elements That Define the Gene Editing Market?

Gene editing is a technology that allows genetic material to change genetic code at a particular location in a genome. It involves cell line engineering, animal genetic engineering, and plant genetic engineering.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2486

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model